Lv3
310 积分 2023-02-28 加入
The 6‐minute walk test as a new outcome measure in Duchenne muscular dystrophy
2天前
已完结
Development of a Functional Assessment Scale for Ambulatory Boys with Duchenne Muscular Dystrophy
7天前
已完结
The latest developments in synthetic approaches to duchenne muscular dystrophy
7天前
已完结
Long-term treatment of SOD1 ALS with tofersen: a multicentre experience in 17 patients
18天前
已完结
Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder Tumors
1个月前
已完结
A Comprehensive Review of Current Approaches in Bladder Cancer Treatment
1个月前
已完结
Intravesical gemcitabine versus anthracyclines for primary and first recurrent non-muscle-invasive bladder cancer: a single-center retrospective study over 10 years
1个月前
已完结
Sequential Gemcitabine plus Docetaxel Is the Standard Second-line Intravesical Therapy for BCG-unresponsive Non–muscle-invasive bladder cancer: Pro
1个月前
已完结
Final results from a national multicenter phase II trial of combination bacillus Calmette-Guérin plus interferon α-2B for reducing recurrence of superficial bladder cancer☆
2个月前
已完结
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline
2个月前
已完结
皖公网安备34019202002308
